WPI 2266 (Acitretin 25 mg)
Pill with imprint WPI 2266 is Brown & Yellow, Capsule-shape and has been identified as Acitretin 25 mg. It is supplied by Actavis Pharma, Inc..
Acitretin is used in the treatment of psoriasis; pityriasis rubra pilaris; psoriatic arthritis and belongs to the drug class antipsoriatics. Not for use in pregnancy. Acitretin 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2266
Acitretin
- Imprint:
- WPI 2266
- Strength:
- 25 mg
- Color:
- Brown & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antipsoriatics
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00591-2266
More about acitretin
- Acitretin Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 19 Reviews
- Drug class: antipsoriatics
Consumer resources
Other brands: Soriatane
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
